Search Results 111-120 of 17366 for Bupropion

  1. Ethinyl estradiol and norgestrel (oral route) - Side effects & dosage - Mayo Clinic

    Bupropion; Butabarbital; Butalbital; Carbamazepine; Carbenicillin; Cefaclor; Cefadroxil; Cefdinir; Cefditoren; Cefixime; Cefpodoxime; Cefprozil; Ceftazidime ...

  2. Mayo Clinic Q and A: Year-round treatment for SAD recommended in some cases

    The antidepressant medication bupropion is FDA approved for the prevention of SAD. Other antidepressant medications may be effective, as well. These ...

  3. Weekend Wellness: Breaking a smoking habit? Seek medical professional help - Mayo Clinic News Network

    For example, bupropion can help control nicotine cravings. Varenicline can reduce both the pleasurable effects of smoking and lessen nicotine withdrawal ...

  4. Mefenamic acid (oral route) - Side effects & dosage - Mayo Clinic

    Bupropion; Calcium Carbonate; Cangrelor; Celecoxib; Certoparin; Chlorothiazide; Chlorthalidone; Choline Magnesium Trisalicylate. Show More. Using this medicine ...

  5. Dapagliflozin, saxagliptin, and metformin (oral route) - Side effects & dosage - Mayo Clinic

    Bupropion; Cannabidiol; Capmatinib; Carbamazepine; Ceritinib; Chloroquine; Chlorothiazide; Chlorthalidone; Cimetidine; Ciprofloxacin; Clarithromycin; Cobicistat ...

  6. A Study of Individualized Obesity Pharmacotherapy Based on Obesity Phenotypes - Mayo Clinic

    No contraindications to the FDA-approved medications: Phentermine-Topiramate Extended Release; Phentermine; ; Oral naltrexone extended-release/bupropion ...

  7. A Study of Tamoxifen Citrate for Treating Patients with Metastatic or Recurrent Breast Cancer - Mayo Clinic

    Bupropion (Wellbutrin); Quinidine (Cardioquin). May not initiate bisphosphonate therapy while receiving treatment on this study. If have begun receiving ...

  8. A Study of LY2784544 for Patients with Myeloproliferative Disorders - Mayo Clinic

    ... bupropion); Currently being treated with warfarin or one of its derivatives which is known to alter levels of protein C or protein S. An exception to this ...

  9. DAYBREAK: Phase 2 Study in Patients With Specific Gene Defects in the MC4R Pathway - Mayo Clinic

    ... bupropion). Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to the dose approved for the treatment of diabetes mellitus (e.g. ...

  10. Study of LY2784544 Testing Alternative Dosing in Participants with Myeloproliferative Neoplasms - Mayo Clinic

    ... bupropion); Have received a hematopoietic stem cell transplant; Have a second primary malignancy that in the judgment of the investigator and sponsor, may ...